ACADIA HEALTHCARE COMPANY INC

NASDAQ: ACHC (Acadia Healthcare Company, Inc.)

Last update: yesterday, 12:14AM

15.47

0.83 (5.67%)

Previous Close 14.64
Open 14.67
Volume 4,545,053
Avg. Volume (3M) 3,068,119
Market Cap 1,428,601,856
Price / Earnings (TTM) 13.34
Price / Earnings (Forward) 7.79
Price / Sales 0.480
Price / Book 0.500
52 Weeks Range
12.63 (-18%) — 47.08 (204%)
Earnings Date 5 Nov 2025
Profit Margin 5.94%
Operating Margin (TTM) 10.19%
Diluted EPS (TTM) 2.04
Quarterly Revenue Growth (YOY) 0.30%
Quarterly Earnings Growth (YOY) -89.00%
Total Debt/Equity (MRQ) 74.09%
Current Ratio (MRQ) 1.35
Operating Cash Flow (TTM) 462.46 M
Levered Free Cash Flow (TTM) -276.20 M
Return on Assets (TTM) 5.06%
Return on Equity (TTM) 6.33%

Market Trend

Short Term Medium Term
Industry Medical Care Facilities (US) Mixed Mixed
Medical Care Facilities (Global) Mixed Mixed
Stock Acadia Healthcare Company, Inc. Bearish Bearish

AIStockmoo Score

-0.4
Analyst Consensus -0.5
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 2.5
Technical Oscillators -4.0
Average -0.38

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ACHC 1 B - 13.34 0.500
HCSG 1 B - 34.24 2.67
INNV 716 M - - 2.82
TOI 314 M - - 0.760
CCRN 262 M - - 0.860
AIRS 220 M - - 2.50

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.

Sector Healthcare
Industry Medical Care Facilities
Investment Style Small Value
% Held by Insiders 1.75%
% Held by Institutions 109.93%

Ownership

Name Date Shares Held
Abrams Bison Investments, Llc 30 Sep 2025 4,380,000
52 Weeks Range
12.63 (-18%) — 47.08 (204%)
Price Target Range
13.00 (-15%) — 30.00 (93%)
High 30.00 (Raymond James, 93.92%) Buy
Median 19.50 (26.05%)
Low 13.00 (B of A Securities, -15.97%) Sell
Average 20.30 (31.22%)
Total 6 Buy, 3 Hold, 1 Sell
Avg. Price @ Call 16.28
Firm Date Target Price Call Price @ Call
Barclays 04 Dec 2025 14.00 (-9.50%) Hold 14.64
06 Nov 2025 17.00 (9.89%) Hold 20.26
B of A Securities 03 Dec 2025 13.00 (-15.97%) Sell 14.69
10 Sep 2025 25.00 (61.60%) Hold 21.06
Cantor Fitzgerald 03 Dec 2025 17.00 (9.89%) Hold 14.69
07 Nov 2025 22.00 (42.21%) Hold 19.51
Deutsche Bank 03 Dec 2025 20.00 (29.28%) Buy 14.69
Keybanc 03 Dec 2025 25.00 (61.60%) Buy 14.69
18 Nov 2025 30.00 (93.92%) Buy 15.01
Leerink Partners 03 Dec 2025 14.00 (-9.50%) Hold 14.69
RBC Capital 03 Dec 2025 19.00 (22.82%) Buy 14.69
12 Nov 2025 22.00 (42.21%) Buy 17.41
UBS 03 Dec 2025 24.00 (55.14%) Buy 14.69
07 Nov 2025 28.00 (81.00%) Buy 19.51
Guggenheim 10 Nov 2025 27.00 (74.53%) Buy 18.17
Raymond James 03 Oct 2025 30.00 (93.92%) Buy 27.14
Show more

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria